ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Scioderm, Inc. · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
inc.sd
epidermolysis bullosa, amicus therapeutics, scioderm, inc., simplex, recessive dystrophic, junctional non-herlitz, sd-101 6%, sd-101-6.0, allantoin 6%, zorblisa, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 994758
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.